MX9100135A - Metodo para estudiar tejido biologico utilizando particulas monocristalinas - Google Patents

Metodo para estudiar tejido biologico utilizando particulas monocristalinas

Info

Publication number
MX9100135A
MX9100135A MX9100135A MX9100135A MX9100135A MX 9100135 A MX9100135 A MX 9100135A MX 9100135 A MX9100135 A MX 9100135A MX 9100135 A MX9100135 A MX 9100135A MX 9100135 A MX9100135 A MX 9100135A
Authority
MX
Mexico
Prior art keywords
monocristalline
particles
biological tissue
studying biological
studying
Prior art date
Application number
MX9100135A
Other languages
English (en)
Inventor
Ralph Weissleder
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of MX9100135A publication Critical patent/MX9100135A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/14—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
    • G01N2400/22—Dextran
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/20—Magnetic particle immunoreagent carriers the magnetic material being present in the particle core
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/30—Magnetic particle immunoreagent carriers the magnetic material being dispersed in the polymer composition before their conversion into particulate form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX9100135A 1990-07-06 1991-07-08 Metodo para estudiar tejido biologico utilizando particulas monocristalinas MX9100135A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54943490A 1990-07-06 1990-07-06
US72506091A 1991-07-03 1991-07-03

Publications (1)

Publication Number Publication Date
MX9100135A true MX9100135A (es) 1992-02-28

Family

ID=27069131

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100135A MX9100135A (es) 1990-07-06 1991-07-08 Metodo para estudiar tejido biologico utilizando particulas monocristalinas

Country Status (3)

Country Link
US (1) US5492814A (es)
IL (1) IL98744A0 (es)
MX (1) MX9100135A (es)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE132350T1 (de) * 1985-03-19 1996-01-15 Randell L Mills Verfahren und system zur erzielung einer lokalen mössbauer-absorption in einem organischen medium
GB9020075D0 (en) * 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
US5948384A (en) * 1990-09-14 1999-09-07 Syngenix Limited Particulate agents
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
DE4239442C2 (de) * 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
DE4428851C2 (de) * 1994-08-04 2000-05-04 Diagnostikforschung Inst Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie
DE19508772C2 (de) * 1995-03-01 1998-01-29 Schering Ag Verfahren und Verbindungen zur Detektion von Analyten mittels Remanenzmessung und deren Verwendung
ZA962939B (en) * 1995-04-12 1997-10-13 Quest Int Oral care compositions.
US6103468A (en) * 1997-10-07 2000-08-15 Labatt Brewing Company Limited Rapid two-stage polymerase chain reaction method for detection of lactic acid bacteria in beer
WO1999019000A1 (en) * 1997-10-11 1999-04-22 The Research Foundation Of State University Of New York Controlled size polymeric microspheres with superparamagnetic cores
FR2777355B1 (fr) 1998-04-10 2000-05-12 Bio Merieux Procede de fixation d'une molecule biologique sur la surface d'un support constitue de silice ou d'oxyde metallique
US6205349B1 (en) * 1998-09-29 2001-03-20 Siemens Medical Systems, Inc. Differentiating normal living myocardial tissue, injured living myocardial tissue, and infarcted myocardial tissue in vivo using magnetic resonance imaging
US6511967B1 (en) * 1999-04-23 2003-01-28 The General Hospital Corporation Use of an internalizing transferrin receptor to image transgene expression
SE9903183D0 (sv) * 1999-09-08 1999-09-08 Europ I Of Science Ab Selektivt bindande och magnetiskt påverkbara nanopartiklar för medicinskt bruk
JP4751556B2 (ja) * 2000-02-28 2011-08-17 ジーンシーグス， インコーポレイテッド ナノカプセルカプセル化システムおよび方法
GB0007239D0 (en) * 2000-03-24 2000-05-17 Nycomed Imaging As Use
FR2808026B1 (fr) * 2000-04-25 2002-06-14 Alexandre Laurent Biomateriau a base de polymere hydrophile presentant un signal specifique en imagerie par resonance magnetique et procede de preparation d'un tel biomateriau
US7169618B2 (en) * 2000-06-28 2007-01-30 Skold Technology Magnetic particles and methods of producing coated magnetic particles
US6669926B1 (en) * 2000-10-16 2003-12-30 Mallinckrodt, Inc. Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients
US6673334B1 (en) * 2000-10-16 2004-01-06 Mallinkcrodt, Inc. Light sensitive compounds for instant determination of organ function
US20030120151A1 (en) * 2001-01-10 2003-06-26 Johns Hopkins University Magnetic resonance imaging methods and compositions
DE10152407A1 (de) * 2001-10-24 2003-05-08 Aesculap Ag & Co Kg Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten
US7018849B2 (en) * 2002-01-15 2006-03-28 Piasio Roger N Process for (A) separating biological/ligands from dilute solutions and (B) conducting an immunochromatographic assay thereof employing superparamagnetic particles throughtout
US20030185757A1 (en) * 2002-03-27 2003-10-02 Mayk Kresse Iron-containing nanoparticles with double coating and their use in diagnosis and therapy
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
DE10224352A1 (de) * 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
FR2855315B1 (fr) * 2003-05-23 2005-08-19 Centre Nat Rech Scient Ferrofluides stables en milieu neutre et ferrofluides modifies obtenus par modification de la surface des particules de ces ferrofluides
US20080299047A1 (en) * 2003-07-31 2008-12-04 National Cheng Kung University Method for preparation of water-soluble and dispersed iron oxide nanoparticles and application thereof
TW588018B (en) * 2003-07-31 2004-05-21 Univ Nat Cheng Kung Method for preparation of water-soluble and dispersed iron oxide nanoparticles and application thereof
DE10350248A1 (de) * 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
GB0405552D0 (en) * 2004-03-12 2004-04-21 Magnet Attraction Ltd Methods for the targetted delivery of biological molecules
US20060018835A1 (en) * 2004-04-02 2006-01-26 General Electric Company Nanoparticles with inorganic core and methods of using them
EP1765162A4 (en) * 2004-05-18 2008-10-01 Gen Electric CONTRASTING AGENTS FOR MAGNETIC RESONANCE TOMOGRAPHY
US20050260137A1 (en) * 2004-05-18 2005-11-24 General Electric Company Contrast agents for magnetic resonance imaging
US20060051290A1 (en) * 2004-07-13 2006-03-09 William Marsh Rice University Short carbon nanotubes as adsorption and retention agents
US20080118440A1 (en) * 2004-08-23 2008-05-22 The General Hospital Corporation Imaging Cellular Nucleic Acids
CA2923748C (en) * 2005-03-21 2017-06-20 The Regents Of The University Of California Functionalized magnetic nanoparticles and methods of use thereof
CA2606924C (en) 2005-05-09 2013-04-16 The General Hospital Corporation Water relaxation-based sensors
US20100166669A1 (en) * 2005-06-28 2010-07-01 Joslin Diabetes Center, Inc. Methods of imaging inflammation in pancreatic islets
EP1738773A1 (de) * 2005-06-29 2007-01-03 Schering AG Magnetische Eisenoxidpartikel enthaltende Zusammensetzung und deren Vervendung in bildgebenden Verfahren
IL169678A (en) 2005-07-14 2010-11-30 Innova Sa Sweetener compositions
EP1912564A2 (en) * 2005-08-09 2008-04-23 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College In vivo imaging and therapy with magnetic nanoparticle conjugates
AU2006284832B2 (en) * 2005-08-31 2011-06-02 T2 Biosystems Inc. NMR device for detection of analytes involving magnetic particles
WO2007044867A2 (en) * 2005-10-11 2007-04-19 Huntington Medical Research Institutes Imaging agents and methods of use thereof
DE102005059751A1 (de) * 2005-12-09 2007-06-14 Ferropharm Gmbh Forschungslabor Wässrige Dispersion von superparamagnetischen Eindomänenteilchen, deren Herstellung und Verwendung zur Diagnose und Therapie
CZ301067B6 (cs) * 2006-02-24 2009-10-29 Ústav makromolekulární chemie AV CR Superparamagnetické nanocástice na bázi oxidu železa s modifikovaným povrchem, zpusob jejich prípravy a použití
WO2007115033A2 (en) * 2006-03-31 2007-10-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Layered nanoparticles for sustained release of small molecules
US20070258907A1 (en) * 2006-04-24 2007-11-08 Davis Mark E Polymer-coated paramagnetic particles
GB2439747A (en) * 2006-07-03 2008-01-09 Uni Degli Studi Di Urbino Carl Delivery of contrasting agents for magnetic resonance imaging
GB0618514D0 (en) * 2006-09-20 2006-11-01 Univ Nottingham Trent Method of detecting interactions on a microarray using nuclear magnetic resonance
US8368402B2 (en) * 2006-11-08 2013-02-05 T2 Biosystems, Inc. NMR systems for in vivo detection of analytes
PT2319804E (pt) * 2006-12-14 2014-11-24 Novartis Ag Adsorvente de fosfato à base de ferro (iii)-carboidrato
WO2008086534A1 (en) 2007-01-11 2008-07-17 Huntington Medical Research Institutes Imaging agents and methods of use thereof
US8421458B2 (en) * 2007-09-28 2013-04-16 T2 Biosystems, Inc. NMR diagnostics by means of a plastic sample container
US20100233089A1 (en) * 2007-10-05 2010-09-16 Huntington Medical Research Institutes Imaging of genetic material with magnetic resonance
CA2704674A1 (en) 2007-11-06 2009-05-14 T2 Biosystems, Inc. Small magnet and rf coil for magnetic resonance relaxometry
JP2011503232A (ja) 2007-11-20 2011-01-27 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 免疫応答の調節
DE102007059939A1 (de) 2007-12-12 2009-06-18 Müller-Schulte, Detlef, Dr. Auflösbare, magnetische und unmagnetische Polymerträger zur Abtrennung und Wiedergewinnung von Zellen und Biosubstanzen
US8246932B2 (en) * 2008-03-28 2012-08-21 General Electric Company Non-radioactive traceable metal isotope-enriched nanoparticles and method of their use for determining biodistribution
EP2274024B1 (en) * 2008-04-03 2013-05-15 Koninklijke Philips Electronics N.V. Biocompatible products for magnetic particle imaging
WO2009129265A1 (en) * 2008-04-14 2009-10-22 Huntington Medical Research Institutes Methods and apparatus for pasadena hyperpolarization
JP5497006B2 (ja) 2008-04-14 2014-05-21 ザ ジェネラル ホスピタル コーポレイション 膵管腺癌の検出および治療のためのプレクチン−１標的化剤
AU2009308841B2 (en) 2008-10-29 2014-07-17 T2 Biosystems, Inc. NMR detection of coagulation time
US20100119608A1 (en) * 2008-11-11 2010-05-13 Jinhyuk Fred Chung Synthesis of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles
DE102008060708A1 (de) 2008-12-05 2010-06-17 Dianogen Gmbh Beschichtung von Kunststoffsubstraten für den medizinischen Einsatz zur Verbesserung der bildgebenden Eigenschaften
US8580230B2 (en) * 2009-02-23 2013-11-12 Kent State University Materials and methods for MRI contrast agents and drug delivery
JP5841044B2 (ja) 2009-03-23 2016-01-06 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． 複合糖質ワクチン
EP2416806B8 (en) * 2009-04-10 2017-03-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Fucoidans as ligands for the diagnosis of degenerative pathologies
US9149024B2 (en) 2009-06-22 2015-10-06 Massachusetts Eye & Ear Infirmary Islet1 (Isl1) and hearing loss
JP2013526616A (ja) 2010-05-26 2013-06-24 ザ ジェネラル ホスピタル コーポレイション 磁性ナノ粒子
US9636423B2 (en) 2010-06-02 2017-05-02 The General Hospital Corporation Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo
IT1401487B1 (it) * 2010-07-29 2013-07-26 Consiglio Nazionale Ricerche Idrossiapatite intrinsecamente magnetica
IL208594A (en) 2010-10-10 2014-11-30 Innova Sa The sweet preparations containing an octopus melting mixture from combination cellulose and sweetening sugar and methods for making them
US8409807B2 (en) 2010-10-22 2013-04-02 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
CA2815085C (en) 2010-10-22 2022-06-21 T2 Biosystems, Inc. Nmr systems and methods for the rapid detection of analytes
US8563298B2 (en) 2010-10-22 2013-10-22 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
US8662213B2 (en) * 2011-01-10 2014-03-04 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Locomotion of amorphous surface robots
US8679858B2 (en) * 2011-01-11 2014-03-25 The Board Of Trustees Of The Leland Stanford Junior University Lanthanide mass dots: nanoparticle isotope tags
KR101303567B1 (ko) * 2011-03-08 2013-09-23 주식회사 인트론바이오테크놀로지 카르복실기가 도입된 만난으로 코팅된 자기공명영상 조영제 및 그것의 제조 방법
WO2013010080A1 (en) 2011-07-13 2013-01-17 T2 Biosystems, Inc. Nmr methods for monitoring blood clot formation
WO2013043858A1 (en) 2011-09-21 2013-03-28 T2 Biosystems, Inc. Nmr methods for endotoxin analysis
US9474810B2 (en) * 2012-03-02 2016-10-25 General Electric Company Superparamagnetic nanoparticles with PEG substituted α-hydroxy phosphonate shells
EP2839038B1 (en) 2012-04-20 2019-01-16 T2 Biosystems, Inc. Compositions and methods for detection of candida species
WO2013187954A1 (en) 2012-06-12 2013-12-19 The General Hospital Corporation Magnetic labeling of bacteria
EP2929047A4 (en) 2012-12-07 2016-08-03 T2 Biosystems Inc Methods for monitoring tight clot formation
ITTV20130027A1 (it) * 2013-02-28 2014-08-29 Mbn Nanomaterialia Spa Procedimento per la produzione di particelle sub-micrometriche e loro uso teranostico in oncologia con una specifica apparecchiatura.
ES2803506T3 (es) * 2013-03-11 2021-01-27 Endomagnetics Ltd Soluciones hipoosmóticas para la detección de ganglios linfáticos
TWI491881B (zh) * 2013-10-18 2015-07-11 國立臺灣大學 胜肽組織化學診斷法
WO2015108783A1 (en) 2014-01-16 2015-07-23 The Brigham And Women's Hospital, Inc. Targeted delivery of immunoregulatory drugs
US10231476B2 (en) 2014-04-04 2019-03-19 Douxmatok Ltd Sweetener compositions and foods, beverages, and consumable products made thereof
US20160242439A1 (en) 2014-04-04 2016-08-25 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US10207004B2 (en) 2014-04-04 2019-02-19 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
CN111700877A (zh) 2014-09-03 2020-09-25 吉倪塞思公司 治疗性纳米粒子和相关的组合物、方法和系统
US20180071376A1 (en) 2015-03-23 2018-03-15 The Brigham And Women`S Hospital, Inc. Tolerogenic nanoparticles for treating diabetes mellitus
JP7523776B2 (ja) 2016-01-21 2024-07-29 ティー２ バイオシステムズ，インコーポレーテッド 細菌を迅速に検出するｎｍｒ法及びシステム
JP6395880B2 (ja) * 2017-02-14 2018-09-26 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 変性病変の診断のためのリガンドとしてのフコイダン
CA3130103A1 (en) 2019-02-13 2020-08-20 The Brigham And Women's Hospital, Inc. Anti-peripheral lymph node addressin antibodies and uses thereof
EP4076537A4 (en) * 2019-12-20 2024-02-28 University of Maryland, Baltimore NON-INVASIVE QUANTIFICATION OF FULL CAPSIDS VS. VACUUMS USING PROTON NMR OF WATER
DE102021115439A1 (de) 2021-06-15 2022-12-15 Chiracon Gmbh Verfahren zur Herstellung von superparamagnetischen Kleinstpartikeln aus Eisenoxid als Kontrastmittel für die MRT-Tomographie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672040A (en) * 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
US4859450A (en) * 1984-08-13 1989-08-22 The General Hospital Corporation Method of NMR imaging using antibody to cardiac myosin
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US5055288A (en) * 1987-06-26 1991-10-08 Advanced Magnetics, Inc. Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxides
US5314679A (en) * 1986-07-03 1994-05-24 Advanced Magnetics Inc. Vascular magnetic resonance imaging agent comprising nanoparticles
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
ATE139431T1 (de) * 1988-08-04 1996-07-15 Advanced Magnetics Inc Von einem rezeptor induziertes kontrastmittel für den endocytose-typ mri

Also Published As

Publication number Publication date
IL98744A0 (en) 1992-07-15
US5492814A (en) 1996-02-20

Similar Documents

Publication Publication Date Title
MX9100135A (es) Metodo para estudiar tejido biologico utilizando particulas monocristalinas
DK138090D0 (da) Diagnostisk analysemetode
IT9020430A0 (it) metodo di analisi
DE69126069D1 (de) Gerät zur Teilchenbildanalyse
DE69122423D1 (de) Vorrichtung zur Blutentnahme
DE69422070D1 (de) Kompakter Blut-Kultur-Apparat
DE69116006D1 (de) Vorrichtung zur Blutentnahme
DK35191A (da) Biologisk insektbekaempelsesmiddel
KR930701110A (ko) 곤충의 생물학적 퇴치 장치 및 그 방법
FI921618A7 (fi) Modifioitu biologinen materiaali
FI962866L (fi) Menetelmä S(+)-ibuprofeeni-partikkeleiden valmistamiseksi
DE69026864D1 (de) Sprachlabor-System
FI901417A7 (fi) Menetelmä pintarakenteiden tutkimista varten
FI964821L (fi) Menetelmä parannettujen biologisten torjunta-aineiden valmistamiseksi
DE69215394D1 (de) System zur Blutanalyse
FI973469L (fi) Menetelmä tekijän IX valmistamiseksi biologisista lähteistä
FI904357A7 (fi) Menetelmä proteiinin C aktivoimiseksi
KR920701821A (ko) 알부민-테트라졸륨 상호작용을 이용한 분석방법
FI922197A7 (fi) Menetelmä ihmisen T-solujen pinta-antigeenien määrittämiseksi
ES1033147Y (es) Dispositivo para la manipulacion de racimos de platanos.
DE69120253D1 (de) Apparat zur fluoreszenzanalyse
IT1248885B (it) Metodo e composizione per il trattamento di deiezioni animali
DK256790D0 (da) Fremgangsmaade ved biologisk rensning
BG95343A (bg) Метод за обработване на протеинови вещества
FI914350A7 (fi) Lääketieteellinen tilastollinen analysointimenetelmä